JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumgartner, D.
Right arrow Articles by Stein, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumgartner, D.
Right arrow Articles by Stein, J. I.
Related Collections
Right arrow Congenital - acyanotic
Right arrow Great vessels

J Thorac Cardiovasc Surg 2006;132:811-819
© 2006 The American Association for Thoracic Surgery


Surgery for Acquired Cardiovascular Disease

Different patterns of aortic wall elasticity in patients with Marfan syndrome: A noninvasive follow-up study

Daniela Baumgartner, MDa,1,*, Christian Baumgartner, PhDb,1, Elisabeth Schermer, MDa, Georg Engl, MDa, Ulrich Schweigmann, MDa, Gabor Mátyás, PhDc,d, Beat Steinmann, MDc, Jörg Ingolf Stein, MDa

a Department of Pediatric Cardiology, Innsbruck Medical University, Innsbruck, Austria
b Research Group for Clinical Bioinformatics, Institute of Biomedical Engineering, University for Health Sciences, Medical Informatics and Technology Hall, Tyrol, Austria
c Division of Metabolism and Molecular Pediatrics, University Children's Hospital, Zurich, Switzerland
d Division of Medical Molecular Genetics and Gene Diagnostics, Institute of Medical Genetics, University of Zurich, Schwerzenbach, Switzerland.

Received for publication April 22, 2006; revisions received June 20, 2006; accepted for publication July 7, 2006.

* Address for reprints: Daniela Baumgartner, MD, Department of Pediatric Cardiology, Innsbruck Medical University, Anichstrasse 35, A 6020 Innsbruck, Austria. (Email: daniela.baumgartner{at}uibk.ac.at).

Objective: Aortic complications determine the life expectancy of most patients with Marfan syndrome. To find out whether there is heterogenous aortic involvement among patients and, if there is, to characterize aortic patterns and response to long-term ß-blocker therapy, we investigated aortic elastic properties before and during ß-blocker treatment.

Methods: In 46 patients with Marfan syndrome (age, 17.4 ± 11.1 years) and 46 healthy control subjects, ascending and descending aortic elastic parameters were determined noninvasively before and after 39 ± 16 months of ß-blocker treatment with atenolol.

Results: Aortic diameters and distensibility distinguished Marfan patients and controls with a sensitivity of 85% and a specificity of 87%. Cluster analysis revealed 4 patterns of aortic phenotypic expression: (1) reduced ascending aortic elasticity (46% of patients), (2) diminished ascending and descending aortic elasticity (17%), (3) minimal alterations of ascending and descending aortic elasticity (20%), and (4) reduced descending aortic elasticity (17%). During follow-up, aortic elastic properties improved in 21 (70%) of 30 patients and deteriorated in 9 (30%) irrespective of ß-blocker dosage. Improvement was observed in 100% of patients (n = 7; age, 5.3 ± 4.2 years) with end-diastolic aortic root diameters between 20 and 30 mm and in 61% of patients (14/23; age, 20.5 ± 10.0 years) with root diameters between 30 and 52 mm.

Conclusions: Aortic elastic parameters distinguish between patients with Marfan syndrome and healthy controls and show the pattern of regional aortic involvement. Improvement or deterioration during follow-up can influence therapeutic decisions to prevent aortic dissection and rupture. Young age, small root diameter, and high distensibility are favorable prognostic factors.



Abbreviations and Acronyms AscAo = ascending aorta; DescAo = descending aorta; FBN1 = the gene encoding fibrillin 1; MFS = Marfan syndrome; MSAI = maximum systolic area increase





This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
H. Shimizu, H. Kasahara, A. Nemoto, K. Yamabe, T. Ueda, and R. Yozu
Can early aortic root surgery prevent further aortic dissection in Marfan syndrome?
Interact CardioVasc Thorac Surg, February 1, 2012; 14(2): 171 - 175.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. W.Y. Chung, H. H. C. Yang, M. W. Radomski, and C. van Breemen
Long-Term Doxycycline Is More Effective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 and -9
Circ. Res., April 25, 2008; 102(8): e73 - e85.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Girdauskas, T. Kuntze, M. A. Borger, T. Doenst, M. Mochalski, T. Walther, V. Falk, and F. W. Mohr
Long-Term Prognosis of Type A Aortic Dissection in Non-Marfan Patients With Histologic Pattern of Cystic Medial Necrosis
Ann. Thorac. Surg., March 1, 2008; 85(3): 972 - 977.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.